Heterogeneity of cytotoxic T cell infiltration in breast and colorectal cancer

por Ziai, James, Gilbert, Houston, Foreman, Oded, Eastham-Anderson, Jeffrey, Chu, Felix, Huseni, Mahrukh, Kim, Jeong M
Publicado 2015

CD8+ T cell infiltration in breast and colon cancer: A histologic and statistical analysis

por Ziai, James, Gilbert, Houston N., Foreman, Oded, Eastham-Anderson, Jeffrey, Chu, Felix, Huseni, Mahrukh, Kim, Jeong M.
Publicado 2018

A CD4/Foxp3/OX40 triple immunofluorescence assay determines association between T cell immune subsets and outcome in colorectal cancer

por Ziai, James, Huseni, Mahrukh, Foreman, Oded, Eastham-Anderson, Jeffrey, Xiao, Yuanyuan, Chu, Felix, Kowanetz, Marcin, Hegde, Priti S, Kim, Jeong
Publicado 2014

Prevalence analysis of OX40-positive cell populations in solid tumors

por Ziai, James, Frantz, Gretchen, Zhang, Liping, Kozlowski, Cleopatra, Gilbert, Houston, Smith, Jacquelyn, Kowanetz, Marcin, Kim, Jeong M, Huseni, Mahrukh
Publicado 2015

Anti-tumor efficacy and biomarker evaluation of agonistic anti-OX40 antibodies in preclinical models

por Huseni, Mahrukh, Totpal, Klara, Du, Changchun, Dalpozzo, Katie, Zhu, Jing, Rishipathak, Deepali, McNamara, Erin, Jonshtone, Bernadette, Hegde, Priti S, Rhee, Ina, Damico-Beyer, Lisa, Kim, Jeong
Publicado 2014

Anti-tumor efficacy and biomarker evaluation of agonistic anti-OX40 antibodies in preclinical models

por Huseni, Mahrukh, Totpal, Klara, Du, Changchun, Dalpozzo, Katie, Zhu, Jing, Rishipathak, Deepali, McNamara, Erin, Jonshtone, Bernadette, Hegde, Priti S, Rhee, Ina, Damico-Beyer, Lisa, Kim, Jeong
Publicado 2014

Development of a robust flow cytometry-based pharmacodynamic assay to detect phospho-protein signals for phosphatidylinositol 3-kinase inhibitors in multiple myeloma

por Li, Congfen, Takahashi, Chikara, Zhang, Liangxuan, Huseni, Mahrukh, Stankovich, Basha, Mashhedi, Haider, Lee, Joanna, French, Dorothy, Anderson, Jeff Eastham, Kim, Doris, Howell, Kathy, Brauer, Matthew J, Kowanetz, Marcin, Yan, Yibing, Humke, Eric, Ebens, Allen, Hampton, Garret, Lackner, Mark R, Hegde, Priti, Jia, Shidong
Publicado 2013

Molecular determinants of response to PD-L1 blockade across tumor types

por Banchereau, Romain, Leng, Ning, Zill, Oliver, Sokol, Ethan, Liu, Gengbo, Pavlick, Dean, Maund, Sophia, Liu, Li-Fen, Kadel, Edward, Baldwin, Nicole, Jhunjhunwala, Suchit, Nickles, Dorothee, Assaf, Zoe June, Bower, Daniel, Patil, Namrata, McCleland, Mark, Shames, David, Molinero, Luciana, Huseni, Mahrukh, Sanjabi, Shomyseh, Cummings, Craig, Mellman, Ira, Mariathasan, Sanjeev, Hegde, Priti, Powles, Thomas
Publicado 2021

First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors

por Kim, Tae Won, Burris, Howard A., de Miguel Luken, Maria J., Pishvaian, Michael J., Bang, Yung-Jue, Gordon, Michael, Awada, Ahmad, Camidge, D. Ross, Hodi, F. Stephen, McArthur, Grant A., Miller, Wilson H., Cervantes, Andres, Chow, Laura Q., Lesokhin, Alexander M., Rutten, Annemie, Sznol, Mario, Rishipathak, Deepali, Chen, Shang-Chiung, Stefanich, Eric, Pourmohamad, Tony, Anderson, Maria, Kim, Jeong, Huseni, Mahrukh, Rhee, Ina, Siu, Lillian L.
Publicado 2022

CD8(+) T cell-intrinsic IL-6 signaling promotes resistance to anti-PD-L1 immunotherapy

por Huseni, Mahrukh A., Wang, Lifen, Klementowicz, Joanna E., Yuen, Kobe, Breart, Beatrice, Orr, Christine, Liu, Li-fen, Li, Yijin, Gupta, Vinita, Li, Congfen, Rishipathak, Deepali, Peng, Jing, Şenbabaoǧlu, Yasin, Modrusan, Zora, Keerthivasan, Shilpa, Madireddi, Shravan, Chen, Ying-Jiun, Fraser, Eleanor J., Leng, Ning, Hamidi, Habib, Koeppen, Hartmut, Ziai, James, Hashimoto, Kenji, Fassò, Marcella, Williams, Patrick, McDermott, David F., Rosenberg, Jonathan E., Powles, Thomas, Emens, Leisha A., Hegde, Priti S., Mellman, Ira, Turley, Shannon J., Wilson, Mark S., Mariathasan, Sanjeev, Molinero, Luciana, Merchant, Mark, West, Nathaniel R.
Publicado 2023